ORDAYBA
Dead / Abandoned — Abandoned — no statement of use filed (as of 03 Jan 2022)
What this means for you
This application is over — abandoned 03 Jan 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87897842
- Mark type
- Stylized text
- Filed
- 27 Apr 2018
- Published for opposition
- 02 Oct 2018
- Abandoned
- 03 Jan 2022
- Attorney of record
- Erica L. Han
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of hereditary angioedema
Owner
- BioCryst Pharmaceuticals, Inc., Durham, NC, US
- BioCryst Pharmaceuticals, Inc., Durham, NC, US
Prosecution history
- 03 May 2023 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 03 Jan 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 03 Jan 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 21 Jul 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Jul 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Jul 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 May 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 May 2021 — SOU EXTENSION 5 GRANTED
- 19 May 2021 — SOU EXTENSION 5 FILED
- 25 May 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 May 2021 — SOU TEAS EXTENSION RECEIVED
- 06 May 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 May 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 May 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Apr 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED